VICTORIA ARCHIBALD: Open Payments
NPI 1780105858 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,101 in 82 payments from 21 companies in 2025. Trend: 2023 $509 · 2024 $1,121 · 2025 $2,101
Food & beverage: $2,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $638 |
| Janssen Biotech, Inc. | 8 | $383 |
| Lilly USA, LLC | 10 | $164 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 7 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| UCB, Inc. | 3 | $70 |
| NeurAxis, Inc. | 1 | $68 |
| Insulet Corporation | 2 | $49 |
Products named: RINVOQ, TREMFYA, SKYRIZI, OMVOH, GIMOTI, VOQUEZNA, ENTYVIO, XIFAXAN.
Industry payments across TX — which companies pay providers there.
